ESSA Pharma Inc (EPIX) Stock

DelistedNasdaq: EPIXESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

0.20
Final close · Oct 7, 2025

EPIX is no longer traded. ESSA Pharma was delisted from the Nasdaq in October 2025.

Prices on this page are historical; the last trade was October 7, 2025 at $0.20.

ESSA Pharma stock price history

Split-adjusted closes, 2015–2025

EPIX final trading statistics

Final close
$0.20
Final trading day
Oct 7, 2025
Market cap at delisting
$9.70M
Shares outstanding
47.31M
Final 52-week range
$0.18 – $6.45
Avg. volume (final 3 mo.)
6,661,670
All-time high (split-adj.)
$245.00 · Jun 2015
All-time low (split-adj.)
$0.19 · Sep 2025
Return since IPO
-99.8%
Beta
1.53
Book value / share
$2.45
Price / book
0.08
Final 52 wk
0.186.45

ESSA Pharma earnings per share

Earnings per share

ESSA Pharma revenue & net income

RevenueNet income

ESSA Pharma annual financials

ESSA Pharma Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2024$0.00-$28.5M-$0.70
FY2023$0.00-$26.6M-$0.60
FY2022$0.00-$35.1M-$0.80
FY2021$0.00-$36.8M-$0.97
FY2020$0.00-$23.4M-$1.04

Last five fiscal years reported before the delisting; fiscal year ending September. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About ESSA Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.

ESSA Pharma stock FAQ

What happened to ESSA Pharma stock?

ESSA Pharma stock was delisted from the Nasdaq. Its final close was $0.20 on October 7, 2025.

Is EPIX stock still trading?

No. EPIX was delisted from the Nasdaq in October 2025 and no longer trades on a U.S. exchange.

What was the last price of EPIX stock?

EPIX closed at $0.20 on its final trading day, October 7, 2025, for a market value of about $9.70M.

What were ESSA Pharma's revenue and earnings in its last full fiscal year?

ESSA Pharma reported revenue of $0.00 and net income of -$28.5M in fiscal 2024, its last full year as a public company.

When did ESSA Pharma go public?

ESSA Pharma Inc stock began trading on July 9, 2015.

Biotechnology stocks to research

All Healthcare stocks →